Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Inflammation
Erschienen in: Inflammation 6/2013

01.12.2013

As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte Ratio

verfasst von: Ahmet Ahsen, Memnune Sena Ulu, Seref Yuksel, Kasım Demir, Mukremin Uysal, Mujgan Erdogan, Gursel Acarturk

Erschienen in: Inflammation | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever (FMF), which is an autosomal recessive disease, is characterised by recurrent febrile episodes in association with peritonitis, pleuritis and arthritis and has ongoing subclinical inflammation during attack-free period. In this study, we aimed to investigate the relationship between FMF with neutrophil-to-lymphocyte ratio (NLR), which is determined in many chronic inflammations as a new potential inflammatory mediator. We included 62 patients and 41 healthy subjects who were similar in terms of age and sex. We found that the NLR values of the patients were significantly higher than those of the control group, and C-reactive protein values were correlated with NLR. Another finding was the NLR values were significantly higher in the FMF patient with M694V mutation than with other mutations. As a result, NLR might be used in the FMF patient as an indicator of the subclinical inflammation, and the FMF patients with M694V mutation should be followed up closely because of increased subclinical inflammation risk.
Literatur
1.
Sohar, E., J. Gafni, M. Pras, et al. 1967. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43: 227–253.PubMedCrossRef
2.
Touitou, I. 2001. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 9: 473–483.PubMedCrossRef
3.
Duzova, A., A. Bakkaloglu, N. Besbas, et al. 2003. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21: 509–514.PubMed
4.
Lachmann, H.J., B. Sengül, and T.U. Yavuzşen. 2006. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45: 746–750.CrossRef
5.
Colak, B., B. Gurlek, Z.A. Yegin, et al. 2008. The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial Mediterranean fever. Ren Fail 30: 187–191.PubMedCrossRef
6.
Kumar, S. 2007. Bilateral disc edema in familial Mediterranean fever. J Clin Diagn Res. 1: 521–524.
7.
The International FMF Consortium. 1997. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90: 797–807.CrossRef
8.
Shohat, M., N. Magal, T. Shohat, et al. 1999. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 7: 287–292.PubMedCrossRef
9.
Livneh, A., P. Langevitz, Y. Shinar, et al. 1999. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid. 6: 1–6.PubMedCrossRef
10.
Ozen, S., Y. Karaaslan, O. Ozdemir, et al. 1998. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25: 2445–2449.PubMed
11.
12.
Arruda-Olson, A.M., G.S. Reeder, M.R. Bell, et al. 2009. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes 26: 656–662.CrossRef
13.
Rudiger, A., O.A. Burckhardt, P. Harpes, et al. 2006. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med 24: 451–454.PubMedCrossRef
14.
Tamhane, U.U., S. Aneja, D. Montgomery, et al. 2008. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 102: 653–657.PubMedCrossRef
15.
Nunez, J., E. Nunez, V. Bodi, et al. 2008. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 101: 747–752.PubMedCrossRef
16.
Walsh, S.R., E.J. Cook, F. Goulder, et al. 2005. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91: 181–184.PubMedCrossRef
17.
Friedman, G.D., I. Tekawa, R.H. Grimm, et al. 1990. The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study. Int J Epidemiol 19: 889–893.PubMedCrossRef
18.
Zahorec, R. 2001. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 1: 5–14.
19.
Turkmen, K., I. Guney, F.H. Yerlikaya, et al. 2012. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail 34: 155–159.PubMedCrossRef
20.
Okyay, G.U., S. Inal, K. Oneç, et al. 2013. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail 35: 29–36.PubMedCrossRef
21.
Solak Y, Yilmaz MI, Sonmez A, et al. 2012 Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp Nephrol doi:10.​1007/​s10157-012-0728-x.
22.
Celikbilek, M., S. Dogan, O. Ozbakır, et al. 2013. Neutrophil–lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 27: 72–76.PubMedCrossRef
23.
Imtiyaz, F., K. Shafique, S.S. Mirza, et al. 2012. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 5: 2.CrossRef
24.
Tunca, M., G. Kirkali, M. Soytürk, et al. 1999. Acute phase response and evolution of familial Mediterranean fever. Lancet 353: 1415.PubMedCrossRef
25.
Korkmaz, C., H. Ozdogan, O. Kasapcopur, et al. 2002. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61: 79–81.PubMedCrossRef
26.
Gerdan, V., I. Sari, D. Kozacı, et al. 2012. Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period. Rheumatol Int 32: 2819–2822.PubMedCrossRef
27.
Aviles, R.J., D.O. Martin, C. Apperson-Hansen, et al. 2003. Inflammation as a risk factor for atrial fibrillation. Circulation 108: 3006–3010.PubMedCrossRef
28.
Aronson, D., M. Boulos, A. Suleiman, et al. 2007. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol 100: 753–757.PubMedCrossRef
29.
Chung, M.K., D.O. Martin, D. Sprecher, et al. 2001. C- reactive protein elevation in patients with atrial arrhythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104: 2886–2891.PubMedCrossRef
30.
Tekin, M., F. Yalcinkaya, N. Cakar, et al. 2000. MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet 57: 430–434.PubMedCrossRef
31.
Yalcinkaya, F., N. Cakar, M. Misirlioğlu, et al. 2000. Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis. Rheumatology (Oxford) 39: 67–72.CrossRef
32.
Tunca, M., S. Akar, F. Onen, et al. 2005. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 84: 1–11.PubMedCrossRef
33.
Samuels, J., I. Aksentijevich, and Y. Torosyan. 1998. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations and a survey of 100 American referrals to the National Institutes of Health. Medicine 77: 268–297.PubMedCrossRef
34.
Booth, D.R., J.D. Gillmore, S.E. Booth, et al. 1998. Pyrin/marenostrin mutations in familial Mediterranean fever. Q J Med 91: 603–606.CrossRef
35.
El-Shanti, H., H.A. Majeed, and M. El-Khateeb. 2006. Familial Mediterranean fever in Arabs. Lancet 367: 1016–1024.PubMedCrossRef
36.
Mimouni, A., N. Magal, N. Stoffman, et al. 2000. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 105: E70.PubMedCrossRef
37.
Ben-Chetrit, E., and R. Backenroth. 2001. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis 60: 146–149.PubMedCrossRef
38.
Brik, R., M. Shinawi, I. Kepten, et al. 1999. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 103: e70.PubMedCrossRef
39.
Cazeneuve, C., T. Sarkisian, C. Pecheux, et al. 1999. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype—genetic and therapeutic implications. Am J Hum Genet 65: 88–97.PubMedCrossRef
40.
Dewalle, M., C. Domingo, M. Rozenbaum, et al. 1998. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 6: 95–97.PubMedCrossRef
41.
Yuksel, S., H. Samli, M. Colbay, et al. 2009. Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. Tohoku J Exp Med 217: 321–327.PubMedCrossRef
42.
Touitou, I., T. Sarkisian, M. Medlej-Hashim, et al. 2007. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Arthritis Rheum 56: 1706–1712.PubMedCrossRef
43.
Ozen S, Demirkaya E, Amaryan G, et al. 2013 Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. doi:10.​1136/​annrheumdis-2012-202708.
44.
Ong, F., H. Vakil, Y. Xue, et al. 2012. The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing to familial Mediterranean fever at UCLA. Clin Genet 1: 1–5.
45.
Kone Paut, I., M. Dubuc, J. Sportouch, et al. 2000. Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford) 39: 1275–1279.CrossRef
46.
Inal, A., M. Yilmaz, S.G. Kendirli, et al. 2009. The clinical and genetical features of 124 children with familial Mediterranean fever: experience of a single tertiary center. Rheumatol Int 29: 1279–1285.PubMedCrossRef
Metadaten
Titel
As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte Ratio
verfasst von
Ahmet Ahsen
Memnune Sena Ulu
Seref Yuksel
Kasım Demir
Mukremin Uysal
Mujgan Erdogan
Gursel Acarturk
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9675-2

Weitere Artikel der Ausgabe 6/2013

Inflammation 6/2013 Zur Ausgabe

OriginalPaper

Cytokine Expression Before and After Aspirin Desensitization Therapy in Aspirin-Exacerbated Respiratory Disease

OriginalPaper

MHV68 Latency Modulates the Host Immune Response to Influenza A Virus

OriginalPaper

Reactive Oxygen Species in Peripheral Blood and Sputum Neutrophils During Bacterial and Nonbacterial Acute Exacerbation of Chronic Obstructive Pulmonary Disease

OriginalPaper

Butyrylcholinesterase and γ-Glutamyltransferase Activities and Oxidative Stress Markers Are Altered in Metabolic Syndrome, But Are Not Affected by Body Mass Index

OriginalPaper

Comparison of the Effects of Desflurane and Propofol Anesthesia on the Inflammatory Response and S100β Protein During Coronary Artery Bypass Grafting

OriginalPaper

Sivelestat Prevents Cytoskeletal Rearrangements in Neutrophils Resulting from Lung Re-expansion Following One-Lung Ventilation During Thoracic Surgery

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise